Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 9, 1166 - 1172 (2003)
Published online: 10 August 2003 | doi:10.1038/nm913
Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities
Masayoshi Shichiri1, Shinya Ishimaru2, Toshio Ota3, Tetsuo Nishikawa3, Takao Isogai3 & Yukio Hirata2
Abstract
The discovery of endogenous bioactive peptides has typically required a lengthy identification process. Computer-assisted analysis of cDNA and genomic DNA sequence information can markedly shorten the process. A bioinformatic analysis of full-length, enriched human cDNA libraries searching for previously unidentified bioactive peptides resulted in the identification and characterization of two related peptides of 28 and 20 amino acids, which we designated salusin-
and salusin-
. Salusins are translated from an alternatively spliced mRNA of TOR2A, a gene encoding a protein of the torsion dystonia family. Intravenous administration of salusin-
or salusin-
to rats causes rapid, profound hypotension and bradycardia. Salusins increase intracellular Ca2+, upregulate a variety of genes and induce cell mitogenesis. Salusin-
stimulates the release of arginine-vasopressin from rat pituitary. Expression of TOR2A mRNA and its splicing into preprosalusin are ubiquitous, and immunoreactive salusin-
and salusin-
are detected in many human tissues, plasma and urine, suggesting that salusins are endocrine and/or paracrine factors.
To read this story in full you will need to login or make a payment (see right).
